An observational study in Lateral Condyle Fractures,Humerus,JakobⅡ Classification,Reduction, sponsored by Shunyou Chen. Completed at 1 site in China. Open to participants aged Up to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-03-19.
Sponsored by Shunyou Chen · Observational
Multi-center Study on Surgical Treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children.
The Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children that were treated with closed or open reduction.
Surgical Treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children.
Exclusion Criteria:
The children were treated with closed reduction.
Procedure: Closed reduction
The children were treated with open reduction.
Procedure: Open reduction
The children were treated with closed reduction.
The children were treated with Open reduction.
Radiographic union
Radiographic union in surgical treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children.
Time frame: Up to 12 weeks.
Fracture displacement
Fracture displacement in surgical treatment for the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children.
Time frame: Up to 12 weeks.
Functional clinical scores
Dhillon scoring system for the outcome of the Displaced JakobⅡ Classification Humerus Lateral Condylar Fractures in Children.
Time frame: Through study completion, an average of 1 year.
This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.